Pan-Facial Layering of Hyaluronic Acid Filler
NCT: NCT07063511 · ACTIVE_NOT_RECRUITING
Brief Summary
Recent advancements in anatomical studies have enabled a more sophisticated approach to treating patients with facial aesthetic concerns with hyaluronic acid (HA) fillers. For instance, volumizing a specific area of concern may be warranted, but it is essential to understand how the underlying patient anatomy is continuing to laxity and hollowness. Varying manufacturing technology have offered a range of HA fillers with different physical and chemical properties adapted to different indications, each one tailored to provide a slightly different outcome based on the needs of the patient. Given these advances in the medical aesthetic field, investigators and clinicians are seeking to develop a new methodology for providing patients with a more tailored and personalized treatment approach. This methodology includes using a pan-facial, multilayering treatment technique that can be employed by injectors once experience is gained with standard techniques. The goal of this study is to assess the efficacy and safety of layering HA from the Restylane line of soft tissue products to create a more harmonious and complete aesthetics results.
Frequently Asked Questions
What is Pan-Facial Layering of Hyaluronic Acid Filler?
Pan-Facial Layering of Hyaluronic Acid Filler is a clinical trial registered under NCT07063511. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07063511?
The current status of NCT07063511 (Pan-Facial Layering of Hyaluronic Acid Filler) is: ACTIVE_NOT_RECRUITING.
When did Pan-Facial Layering of Hyaluronic Acid Filler start?
Pan-Facial Layering of Hyaluronic Acid Filler started on 2025-07-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.